Skip to content

The Ultrasound Guided Versus Land-mark Location Method for Performing Spinal Anesthesia in Obese Parturients

Comparison of Ultrasound and Anatomical Land-mark Method in Spinal Anesthesia for Elective Cesarean Section in Obese Parturients With BMI ≥ 40 kg/m2. A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05342922
Enrollment
80
Registered
2022-04-25
Start date
2022-05-23
Completion date
2023-01-24
Last updated
2023-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Keywords

Spinal Anesthesia, Cesarean Delivery, Ultrasound

Brief summary

This study will be investigated whether an ultrasound-assisted technique is better than a classical land-mark technique to facilitate spinal anesthesia in the lateral position in morbidly obese pregnant women with BMI ≥ 40 who will undergo elective cesarean section. The primary objective in this study is the rate of successful dural puncture at the first attempt. It was assumed that ultrasound could facilitate neuraxial blockade in grade 3 morbidly obese pregnant women according to the Who classification, whose topographic anatomy is difficult.

Detailed description

Spinal anesthesia is the most commonly used anesthesia method for elective cesarean deliveries. Anesthesiologists may have difficulties in determining the poorly palpable surface landmarks in morbidly obese pregnant women. Manual palpation technique, which is preferred in neuraxial anesthesia, may be difficult in obese pregnant women due to the difficulty in identifying bone landmarks. Neuraxial ultrasound examination before spinal anesthesia may help spinal anesthesia performance and decrease number of attempts in obese parturients. This study will be conducted as a single-center, prospective, randomized, double-blinded trial in a university hospital. Patients scheduled for elective cesarean will be screened for enrollment in the study. Patient, the anesthetist administering spinal anesthesia and evaluating the data were blind to the distribution of patient groups.Ultrasonographic examinations were performed by a single investigator trained in this technique who performed more than 150 ultrasound-guided neuraxial blocks.

Interventions

In the operating room, all of the patients will receive standard monitoring. Scans will be made in logiditunal parasagittal and transverse midline views with ultrasound. Needle entry sites in the L2-L3 and L3-L4 intervals will be determined as the intersection of the longiditunal and transverse lines. When the spinal puncture operator is outside the room, Needle entry sites were marked for both groups.After skin marking, the pregnant woman will be asked to remain still and a subarachnoid puncture will be performed immediately. Spinal anesthesia will be administered with injection of intrathecal bupivacaine.

PROCEDURELandmark group

In the Landmark group, the injection site will be determined using the traditional method of palpating the posterior superior iliac spine.When the spinal puncture operator is outside the room, Needle entry sites were marked for both groups.After skin marking, the pregnant woman will be asked to remain still and a subarachnoid puncture will be performed immediately. Spinal anesthesia will be administered with injection of intrathecal bupivacaine.

Sponsors

Karaman Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Triple (Participant,Investigator, Outcomes Assessor)

Intervention model description

Parallel Assignment Allocation: Randomized Intervention Model: Parallel Assignment

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Parturient who will receive selective cesarean delivery under spinal anesthesia * ASA 2-3 scheduled for elective sections * BMI≥40 kg/m2 * normal singleton pregnancy * ≥37 weeks of gestation

Exclusion criteria

* Multiple gestations * Emergency C-section * exist contraindications of spinal anesthesia * Local anesthetics allergy * BMI\<40 kg/m2 * history of lumbar spinal diseases and lumbar surgery * Parturient refusal

Design outcomes

Primary

MeasureTime frameDescription
The success rate of first puncture30 minuteSuccess on a single-puncture attempt will be defined as reaching the subarachnoid space on the first insertion of the needle.

Secondary

MeasureTime frameDescription
dermatome level of sensory block [ Time Frame: 10 minutes after spinal anesthetic injection ]20 minutethoracic dermatome level of sensory block assessed by pinprick test
incidence of postoperative headache72 hour12-72 hours following spinal anesthesia due to CSF leakage
Incidence of hypotension2 hourA systolic arterial pressure decrease of more than 25% from baseline or less than 90 mmHg
Number of skin punctures30 minuteSkin puncture is defined as any separate skin puncture attempt.
Number of needle pass30 minuteNeedle pass is defined as skin puncture plus number of redirection attempts
Failure rate of spinal anesthesia120 minuteNumber of parturients who need additional analgesic drug or conversion to general anesthesia
Time interval to determine needle insertion site30 minuteTime interval between the operator touches the parturient and the completion of the needle insertion point marking
Time taken for spinal injection30 minuteThe time interval between the needle insertion to visualization of cerebrospinal spinal fluid in the spinal needle.
Number of puncture levels30 minuteMove to a second lumbar space after 3 needle insertion attempts
Patient satisfaction The procedure duration30 minutePatients rated their satisfaction as very satisfied, satisfied, or dissatisfied immediately after the procedure.
incidence of complications during puncture30 minuteIncidence of radicular pain, paresthesia, and blood during spinal needle injection
The procedure duration time30 minuteThe duration from initiation of location marking by palpation or ultrasound to obtaining free cerebrospinal fluid flow

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026